• Die Fortschritte der Forschung sind die einzige Hoffnung der Patienten auf wirksame Therapien!

     

  • Unterstützen Sie die Forschung an seltenen genetischen Muskelkrankheiten!

     

Grant opportunity

We are inviting biomedical research proposals aimed at finding therapies for SMA or at elucidating the basic pathophysiological processes of the disease. 

Terms and Conditions

**********************************************

Myology 2022 and mitoNice

Nice,  France, 12-17 September 2022

A joint session in the afternoon of September 15th will ensure a smooth transition between the two congresses.

Abstracts submission postponed to April 15th

********************************************************************

SEAL Therapeutics AG

SEAL Therapeutics and the FSRMM have teamed-up in their desire to make an innovative treatment approach available to LAMA2 MD patients as soon as possible. The foundation has invested in SEAL Therapeutics to support the teams' efforts towards clinical development and registration.

Start-Up's website
News release 23 March 2022

**************************************************************************

New Directions Conference

Ft. Lauderdale, 20-23 June 2022

The biennial meeting is organized by H. Lee Sweeney and Elizabeth McNally. The conference will highlight current developments in muscle biology, disease, and therapy with presentations by leading international researchers.

Abstracts until 20 March/15 May

*******************************************

13th International Myotonic Dystrophy Consortium Meeting

Osaka, Japan, 21-25 June 2022

Hybrid format. An on-demand video recording of the meeting will be available for one month after the conference.

Early bird until April 30th

***********************************************

International Conference on Muscle Wasting

Ascona, 11-16 September 2022

This meeting will focus on the intersection between basic aging mechanisms and their effect on skeletal muscle disease - particular focus will include cachexia, frailty and sarcopenia.

Abstracts until June 5th, registration until August 28th

***********************************************************

 

The 27th International Annual Congress of the World Muscle Society

Halifax, 11-15 October 2022 (hybrid)

The main thematic topics this year are: new developments in congenital muscle disease, neuropathies and non-5q motor neuron disease, the development of therapeutic approaches.

Early bird until June 10th

******************************************************************************************

Early Career Programme

Interested in participating in one of the upcoming ENMC workshops? If you are a young scientist (up to 5 years from your PhD defense) you may be eligible for a free participation.

List of upcoming ENMC workshops
Young Scientists Programme, conditions and guidelines

***************************************************************************

New papers

___________________________________

Integrative molecular roadmap for direct conversion of fibroblasts into myocytes and myogenic progenitor cells.


Kim I, Ghosh A, Bundschuh N, Hinte L, Petrosyan E, von Meyenn F, Bar-Nur O.
Sci Adv. 2022 Apr 8;8(14):eabj4928.

08 April 2022

Skeletal Muscle Disorders: A Non-cardiac Source of Cardiac Troponin T.

du Fay de Lavallaz J, Prepoudis A, Wendebourg MJ, Kesenheimer E, Kyburz D, Daikeler T, Haaf P, Wanschitz J, Löscher WN, Schreiner B, Katan M, Jung HH, Maurer B, Hammerer-Lercher A, Mayr A, Gualandro...

07 April 2022

Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.

Duran-Trio L, Fernandes-Pires G, Grosse J, Soro-Arnaiz I, Roux-Petronelli C, Binz PA, De Bock K, Cudalbu C, Sandi C, Braissant O.
J Inherit Metab Dis. 2022 Mar;45(2):278-291.

31 März 2022

Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland.

Tscherter A, Rüsch CT, Baumann D, Enzmann C, Hasselmann O, Jacquier D, Jung HH, Kruijshaar ME, Kuehni CE, Neuwirth C, Stettner GM, Klein A; Swiss-Reg-NMD group.
Neuromuscul Disord. 2022 Feb...

25 März 2022

Myostatin gene inactivation increases post-mortem calpain-dependent muscle proteolysis in mice.

Nassar R, Vernus B, Carnac G, Fouret G, Goustard B, Casas F, Tintignac L, Cassar-Malek I, Picard B, Seiliez I, Brioche T, Koechlin-Ramonatxo C, Bertrand-Gaday C, Hamade A, Najjar F, Chabi B, Bonnieu...

15 März 2022

Improvement of muscle strength in a mouse model for congenital myopathy treated with HDAC and DNA methyltransferase inhibitors.

Ruiz A, Benucci S, Duthaler U, Bachmann C, Franchini M, Noreen F, Pietrangelo L, Protasi F, Treves S, Zorzato F.
Elife. 2022 Mar 3;11:e73718.

03 März 2022

Enforced tethering elongates the cortical endoplasmic reticulum and limits store-operated calcium entry.

Henry C, Carreras-Sureda A, Demaurex N.
J Cell Sci. 2022 Feb 22:jcs.259313.

22 Februar 2022

Inhibition of sphingolipid de novo synthesis counteracts muscular dystrophy.

Laurila PP, Luan P, Wohlwend M, Zanou N, Crisol B, Imamura de Lima T, Goeminne LJE, Gallart-Ayala H, Shong M, Ivanisevic J, Place N, Auwerx J. Sci Adv. 2022 Jan 28;8(4):eabh4423.

28 Januar 2022

GCN5 maintains muscle integrity by acetylating YY1 to promote dystrophin expression.

Addicks GC, Zhang H, Ryu D, Vasam G, Green AE, Marshall PL, Patel S, Kang BE, Kim D, Katsyuba E, Williams EG, Renaud JM, Auwerx J, Menzies KJ.
J Cell Biol. 2022 Feb 7;221(2):e202104022.

14 Januar 2022

Creatine transporter-deficient rat model shows motor dysfunction, cerebellar alterations, and muscle creatine deficiency without muscle atrophy.

Duran-Trio L, Fernandes-Pires G, Grosse J, Soro-Arnaiz I, Roux-Petronelli C, Binz PA, De Bock K, Cudalbu C, Sandi C, Braissant O.
J Inherit Metab Dis. 2021 Dec 22.

22 Dezember 2021